Global Neomycin Sulphate Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Neomycin Sulphate Market Research Report 2024
Neomycin sulfate is an aminoglycoside antibiotic, which is composed of two or three amino sugar molecules and a non-sugar part called an aglycone aminocyclic alcohol linked by an ether bond.
According to Mr Accuracy reports new survey, global Neomycin Sulphate market is projected to reach US$ 622.6 million in 2029, increasing from US$ 230 million in 2022, with the CAGR of 15.3% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Neomycin Sulphate market research.
As an antibiotic drug, neomycin sulfate will continue to maintain a stable and rapid growth trend in the future in the pharmaceutical field; the demand growth in veterinary drugs and feed additives will be significantly accelerated, especially as feed additives in livestock and poultry breeding. The market will have very broad prospects.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Neomycin Sulphate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Pfizer
Shandong Qifa
Nostrum Laboratories Inc
XGEN PHARMS
Rainbowlabs
Xinyu Pharmaceutical
Renfu Medicine
Jinyao Xinrui Pharmaceutical
Lvkang Biochemical
Lvkang Biochemical
Cyto Bio
Shengxue Dacheng
Chartwell Pharmaceuticals
Luxica Pharma
Segment by Type
Veterinary
Human Use
Hospital
Veterinary Station
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Neomycin Sulphate report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Neomycin Sulphate market is projected to reach US$ 622.6 million in 2029, increasing from US$ 230 million in 2022, with the CAGR of 15.3% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Neomycin Sulphate market research.
As an antibiotic drug, neomycin sulfate will continue to maintain a stable and rapid growth trend in the future in the pharmaceutical field; the demand growth in veterinary drugs and feed additives will be significantly accelerated, especially as feed additives in livestock and poultry breeding. The market will have very broad prospects.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Neomycin Sulphate market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Pfizer
Shandong Qifa
Nostrum Laboratories Inc
XGEN PHARMS
Rainbowlabs
Xinyu Pharmaceutical
Renfu Medicine
Jinyao Xinrui Pharmaceutical
Lvkang Biochemical
Lvkang Biochemical
Cyto Bio
Shengxue Dacheng
Chartwell Pharmaceuticals
Luxica Pharma
Segment by Type
Veterinary
Human Use
Segment by Application
Hospital
Veterinary Station
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Neomycin Sulphate report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source